USD 0.0
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2022 | - USD | 0.0% |
2021 | - USD | -100.0% |
2020 | 557 Thousand USD | -79.99% |
2019 | 2.78 Million USD | 142.69% |
2018 | 1.14 Million USD | 54.03% |
2017 | 744.46 Thousand USD | 111.91% |
2016 | 351.31 Thousand USD | -51.99% |
2015 | 731.77 Thousand USD | -9.08% |
2014 | 804.88 Thousand USD | -56.59% |
2013 | 1.85 Million USD | -35.9% |
2012 | 2.89 Million USD | 84.4% |
2011 | 1.56 Million USD | -25.33% |
2010 | 2.1 Million USD | 56.32% |
2009 | 1.34 Million USD | 46.01% |
2008 | 920.42 Thousand USD | 12.63% |
2007 | 817.18 Thousand USD | -62.1% |
2006 | 2.15 Million USD | 60.25% |
2005 | 1.34 Million USD | -44.34% |
2004 | 2.41 Million USD | 21713.45% |
2003 | 11.08 Thousand USD | 31.66% |
2002 | 8417.00 USD | -64.1% |
2001 | 23.44 Thousand USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q2 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 FY | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2021 FY | - USD | -100.0% |
2021 Q1 | 753 Thousand USD | 35.19% |
2021 Q2 | 803 Thousand USD | 6.64% |
2021 Q3 | 867 Thousand USD | 7.97% |
2020 Q3 | 562 Thousand USD | -13.27% |
2020 FY | 557 Thousand USD | -79.99% |
2020 Q1 | 3.94 Million USD | 41.66% |
2020 Q2 | 648 Thousand USD | -83.56% |
2020 Q4 | 557 Thousand USD | -0.89% |
2019 Q1 | 1.28 Million USD | 11.78% |
2019 Q3 | 1.31 Million USD | -41.85% |
2019 FY | 2.78 Million USD | 142.69% |
2019 Q2 | 2.25 Million USD | 75.82% |
2019 Q4 | 2.78 Million USD | 112.35% |
2018 Q2 | 937.83 Thousand USD | 4.26% |
2018 FY | 1.14 Million USD | 54.03% |
2018 Q4 | 1.14 Million USD | 11.73% |
2018 Q3 | 1.02 Million USD | 9.44% |
2018 Q1 | 899.53 Thousand USD | 0.0% |
2017 FY | 744.46 Thousand USD | 111.91% |
2016 Q1 | 1.72 Million USD | 135.7% |
2016 FY | 351.31 Thousand USD | -51.99% |
2016 Q3 | 462.5 Thousand USD | 3.35% |
2016 Q2 | 447.51 Thousand USD | -74.05% |
2016 Q4 | 351.31 Thousand USD | -24.04% |
2015 FY | 731.77 Thousand USD | -9.08% |
2015 Q4 | 731.77 Thousand USD | 89.83% |
2015 Q1 | 707.2 Thousand USD | -12.14% |
2015 Q3 | 385.49 Thousand USD | -40.84% |
2015 Q2 | 651.56 Thousand USD | -7.87% |
2014 FY | 804.88 Thousand USD | -56.59% |
2014 Q2 | 1.39 Million USD | -14.09% |
2014 Q4 | 804.88 Thousand USD | -28.91% |
2014 Q1 | 1.62 Million USD | -12.13% |
2014 Q3 | 1.13 Million USD | -19.11% |
2013 Q2 | 2.44 Million USD | -5.33% |
2013 FY | 1.85 Million USD | -35.9% |
2013 Q4 | 1.85 Million USD | -20.81% |
2013 Q3 | 2.34 Million USD | -4.08% |
2013 Q1 | 2.57 Million USD | -10.86% |
2012 Q1 | 4.48 Million USD | 186.17% |
2012 Q3 | 3.45 Million USD | -19.2% |
2012 FY | 2.89 Million USD | 84.4% |
2012 Q2 | 4.27 Million USD | -4.66% |
2012 Q4 | 2.89 Million USD | -16.35% |
2011 Q3 | 1.39 Million USD | 1.71% |
2011 Q1 | 1.93 Million USD | -7.94% |
2011 Q2 | 1.37 Million USD | -28.91% |
2011 FY | 1.56 Million USD | -25.33% |
2011 Q4 | 1.56 Million USD | 12.18% |
2010 Q1 | 2.12 Million USD | 57.8% |
2010 Q3 | 2.23 Million USD | -42.84% |
2010 Q4 | 2.1 Million USD | -6.03% |
2010 FY | 2.1 Million USD | 56.32% |
2010 Q2 | 3.91 Million USD | 84.44% |
2009 Q3 | 1.77 Million USD | 3.21% |
2009 Q1 | 1.07 Million USD | 17.31% |
2009 FY | 1.34 Million USD | 46.01% |
2009 Q4 | 1.34 Million USD | -24.15% |
2009 Q2 | 1.71 Million USD | 58.99% |
2008 FY | 920.42 Thousand USD | 12.63% |
2008 Q2 | 716.96 Thousand USD | -14.47% |
2008 Q3 | 857.53 Thousand USD | 19.61% |
2008 Q1 | 838.25 Thousand USD | 2.58% |
2008 Q4 | 920.42 Thousand USD | 7.33% |
2007 Q3 | 992.28 Thousand USD | -59.78% |
2007 FY | 817.18 Thousand USD | -62.1% |
2007 Q4 | 817.18 Thousand USD | -17.65% |
2007 Q2 | 2.46 Million USD | 10.4% |
2007 Q1 | 2.23 Million USD | 3.64% |
2006 Q2 | 1.57 Million USD | 3.9% |
2006 FY | 2.15 Million USD | 60.25% |
2006 Q3 | 2.36 Million USD | 50.46% |
2006 Q4 | 2.15 Million USD | -8.73% |
2006 Q1 | 1.51 Million USD | 12.31% |
2005 Q1 | 2.39 Million USD | -0.87% |
2005 Q3 | 1.67 Million USD | -18.75% |
2005 FY | 1.34 Million USD | -44.34% |
2005 Q4 | 1.34 Million USD | -19.57% |
2005 Q2 | 2.05 Million USD | -14.07% |
2004 Q1 | 499.21 Thousand USD | 4404.76% |
2004 FY | 2.41 Million USD | 21713.45% |
2004 Q4 | 2.41 Million USD | 3.46% |
2004 Q3 | 2.33 Million USD | 437.65% |
2004 Q2 | 434.59 Thousand USD | -12.94% |
2003 Q3 | 54.36 Thousand USD | 1637.98% |
2003 Q4 | 11.08 Thousand USD | -79.62% |
2003 FY | 11.08 Thousand USD | 31.66% |
2003 Q1 | 5665.00 USD | -32.7% |
2003 Q2 | 3128.00 USD | -44.78% |
2002 FY | 8417.00 USD | -64.1% |
2002 Q3 | - USD | -100.0% |
2002 Q2 | 1043.00 USD | -88.47% |
2002 Q1 | 9043.00 USD | -61.43% |
2002 Q4 | 8417.00 USD | 0.0% |
2001 Q3 | 2371.00 USD | 0.0% |
2001 Q4 | 23.44 Thousand USD | 888.82% |
2001 FY | 23.44 Thousand USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Achiko AG | 6.49 Million USD | 100.0% |
Accelera Innovations, Inc | - USD | NaN% |
Aspyra Inc. | 8.37 Million USD | 100.0% |
Cannabis Sativa, Inc. | 1.26 Million USD | 100.0% |
CompuMed, Inc. | 1.34 Million USD | 100.0% |
CompuGroup Medical SE & Co. KGaA | 1.45 Billion USD | 100.0% |
Cogstate Limited | 16.91 Million USD | 100.0% |
CareView Communications, Inc. | 40.52 Million USD | 100.0% |
Craneware plc | 215.06 Million USD | 100.0% |
Caduceus Software Systems Corp. | 5.57 Million USD | 100.0% |
Certive Solutions Inc. | 10.95 Million USD | 100.0% |
Drug Free Solution, Inc. | 333.29 Thousand USD | 100.0% |
DATATRAK International, Inc. | 6.18 Million USD | 100.0% |
Strainsforpains, Inc. | 2.61 Million USD | 100.0% |
Healixa Inc. | 10.57 Million USD | 100.0% |
Easy Technologies Inc. | - USD | NaN% |
eWellness Healthcare Corporation | - USD | NaN% |
Founders Bay Holdings | 138.29 Thousand USD | 100.0% |
Healthcare Integrated Technologies, Inc. | 1.02 Million USD | 100.0% |
H-Source Holdings Ltd. | - USD | NaN% |
InterCare DX, Inc. | 5068.58 USD | 100.0% |
iCoreConnect Inc. | 11.24 Million USD | 100.0% |
IQ-AI Limited | 796.65 Thousand USD | 100.0% |
Cannabiz Mobile, Inc. | 559.05 Thousand USD | 100.0% |
Mednow Inc. | 9.46 Million USD | 100.0% |
Galileo Life Sciences, Inc. | 725.46 Thousand USD | 100.0% |
MediXall Group, Inc. | 4.53 Million USD | 100.0% |
Mitesco, Inc. | 14.13 Million USD | 100.0% |
MobileSmith, Inc. | 6.15 Million USD | 100.0% |
NantHealth, Inc. | 384.94 Million USD | 100.0% |
Net Medical Xpress Solutions, Inc. | 1.07 Million USD | 100.0% |
OneLife Technologies Corp. | - USD | NaN% |
ORHub, Inc. | 11.33 Million USD | 100.0% |
Patient Access Solutions, Inc. | 2.44 Million USD | 100.0% |
Pharma-Bio Serv, Inc. | 3.77 Million USD | 100.0% |
PPJ Healthcare Enterprises, Inc. | 7.03 Million USD | 100.0% |
Medical Cannabis Payment Solutions, Inc. | 2.36 Million USD | 100.0% |
Renalytix Plc | 15.82 Million USD | 100.0% |
Revium Recovery Inc. | 144 Thousand USD | 100.0% |
RYAH Group, Inc. | - USD | NaN% |
Carepay Inc. | 3.06 Million USD | 100.0% |
Vaso Corporation | 48.91 Million USD | 100.0% |
Vynleads, Inc. | 805.33 Thousand USD | 100.0% |